Symposium Header Image

Multi-Cancer Early Detection Symposium

Monday, January 22, 2024  |  8:30 am - 6:00 pm
Byers Auditorium, Genentech Hall
600 16th Street, San Francisco, CA 94158 (view building entrance)

Overview | Agenda | RegistrationContact


Overview

The UCSF Helen Diller Family Comprehensive Cancer Center presents an all-day symposium focused on the opportunities and challenges of Multi-Cancer Early Detection (MCED) tests. Held at the UCSF Mission Bay campus, the symposium will cover a number of topics and issues arising from the advent of MCED tests, including current and emerging technology, clinical implications, reimbursement, access, and equity. There will be a networking reception immediately following the symposium.


Agenda

8:30 am

Check in and breakfast

9:00 am

Introduction

Alan Ashworth, PhD, FRS
President, UCSF Helen Diller Family Comprehensive Cancer Center
Senior Vice President for Cancer Services, UCSF Health

Session I - MCED: Setting the Stage

9:10 am

Cancer Interception

Elizabeth Blackburn, PhD
Nobel Laureate
Professor Emerita, Dept. of Biochemistry and Biophysics, UCSF

9:20 am

Blood-Based Multi-Cancer Early Detection: A Dream or a Nightmare?

Margaret Tempero, PhD
Professor of Medicine, UCSF
Director, UCSF Pancreas Center
Director of Cancer Early Detection and Interception (CEDI) Initiative, UCSF Helen Diller Family Comprehensive Cancer Center

9:40 am

A Personal Journey: The Case for High Throughput Testing for Multiple Cancers 

Pamela Munster, MD
Professor of Medicine, UCSF
Director of Early Phase Clinical Trials Unit
Co-Leader, UCSF Center for BRCA Research

Session II - Discovery and Innovation at UCSF

10:00 am

Building Molecular Barcodes to Store Human Cancer Cell Identity

Hani Goodarzi, PhD
Associate Professor or Biophysics & Biochemistry, UCSF

10:20 am

Leveraging Sequences Missing from the Human Genome to Diagnose Cancer

Nadav Ahituv, PhD
Professor of Bioengineering, UCSF

10:40 am

An Extracellular Vesicle Sequencing Approach for Liquid Biopsy: Applications in Glioma and Pancreatic Cyst Lesions

Stephen Francis, PhD
Associate Professor of Neurological Surgery, UCSF

11:00 am

Break

Session III - Industry at Work: Early Detection Assays

11:15 am

From Single Cancer through Multi-Cancer: Bridging the Gap and Challenging 
the Status Quo

Victoria Raymond, MS
Senior Director Medical Affairs, Guardant Health

11:30 am

Shifting the Paradigm in Cancer Screening: Multi-Cancer Early Detection Testing

Tomasz Beer, MD
CMO, Exact Sciences

11:45 am

Multi-Cancer Early Detection Technology: A New Front in the War on Cancer

Joshua Ofman, MD, MSHS
President, GRAIL

12:00 pm

Exosome Enrichment Enables Effective Early Cancer Detection

Paul Billings, MD, PhD
CEO, Biological Dynamics

12:15 pm

Panel discussion

12:45 pm

Lunch

Session IV - Where the Rubber Meets the Road: What Will Be Needed for MCED to Be Implemented Effectively, Efficiently, and Equitably

1:45 pm

Health Equity in MCED Requires Intentional Action

Kim Rhoads, MD, MPH
Associate Professor of Epidemiology & Biostatistics, UCSF
Director of Office of Community Engagement, UCSF Helen Diller Family Comprehensive Cancer Center

2:05 pm

Addressing Policy Considerations for MCED: Payer Coverage and Economic Value

Kathryn Phillips, PhD
Professor of Health Services Research and Health Economics, Dept. of Clinical Pharmacy, School of Pharmacy
Director/Founder, Center for Translational and Policy Research on Precision Medicine (TRANSPERS), UCSF

2:25 pm

Panel discussion

Session V - Real World Experiences in Population Approaches to Cancer Screening from SF CAN

2:45 pm

SF CAN Introduction

Robert Hiatt, MD, PhD
Professor of Epidemiology and Biostatistics, UCSF

2:55 pm

Colorectal Cancer

Michael Potter, MD
Professor of Clinical Family and Community Medicine, UCSF

3:05 pm

Prostate Cancer

Nynikka Palmer, DrPH, MPH
Associate Professor of General Internal Medicine, UCSF

3:15 pm

Liver Cancer

Rena Fox, MD
Professor of Clinical Medicine, UCSF

3:25 pm

Panel discussion

3:45 pm

Break

Session VI - The WISDOM of Improving Screening and Prevention for Breast Cancer

4:00 pm

Overview

Laura Esserman, MD, MBA
Professor of Surgery and Radiology, UCSF
Director, UCSF Breast Care Center

4:05 pm

How to Translate Knowledge of Breast Cancer Subtypes into Screening Stratification

Laura van ’t Veer, PhD
Professor of Laboratory Medicine, UCSF

4:25 pm

Integrating Genetic Risk Information into Breast Cancer Screening Strategies

Elad Ziv, MD
Professor of Medicine, UCSF

4:45 pm

WISDOM for Screening: Building a Nationwide Screening and Prevention Continuous Learning Platform

Allison Stover Fiscalini, MPH
Director, Athena Breast Health Network

5:05 pm

Panel discussion

5:30 pm

Closing remarks

Margaret Tempero, MD
Professor of Medicine, UCSF
Director, UCSF Pancreas Center
Director of Cancer Early Detection and Interception (CEDI) Initiative, UCSF Helen Diller Family Comprehensive Cancer Center

5:40 pm Reception

Registration

The event is open to all interested members of the UCSF community including primary care physicians, clinical providers, researchers, trainees, and staff.

Registration is now closed -- thank you!


Contact

For general event inquiries, contact:
Kurt Giles, [email protected]

For registration questions, contact:
Erin Hayes, [email protected]